|
|
||||||||
Pediatric Imaging |
1 From the Mallinckrodt Institute of Radiology, Washington University School of Medicine, 510 S Kingshighway Blvd, St Louis, MO 63110 (M.J.S., B.A.S.); Department of Biostatistics, Cleveland Clinic Foundation, Cleveland, Ohio (H.I.); Department of Diagnostic Imaging, St Judes Childrens Hospital, Memphis, Tenn (B.D.F., F.A.H.); Department of Radiology, Childrens Hospital of Philadelphia, Pa (J.S.M.); Departments of Radiology (D.J.) and Health Care Policy (D.J.C., B.J.M.), Harvard Medical School, Boston, Mass; Department of Radiology, C. S. Mott Childrens Hospital, Ann Arbor, Mich (R.J.H.); Department of Pediatric Imaging, Childrens Hospital, Detroit, Mich (S.E.R.); and Department of Radiology, Brigham and Womens Hospital, Boston, Mass (B.J.M.). Received April 25, 2001; revision requested June 15; revision received August 3; accepted September 17. Supported by grant CA59403 from the National Cancer Institute. Address correspondence to M.J.S. (e-mail: siegelm@mir.wustl.edu).
PURPOSE: To compare the accuracies of computed tomography (CT), magnetic resonance (MR) imaging, and bone scintigraphy in staging disease in patients with neuroblastoma.
MATERIALS AND METHODS: Ninety-six children with newly diagnosed neuroblastoma were enrolled in a multicenter prospective cohort study. CT, MR, and bone scintigraphy were used to evaluate tumor stage. Sensitivity and specificity values and receiver operating characteristic (ROC) curve analyses were used to compare the accuracy of CT, MR, and scintigraphy for tumor staging.
RESULTS: Eighty-eight patients were eligible for staging analysis, and 45 patients who underwent surgery at initial diagnosis were eligible for analysis of local tumor extent. CT and MR had sensitivities of 43% and 83%, respectively (P < .01), and specificities of 97% and 88%, respectively (P > .05), for detection of stage 4 disease. Areas under the ROC curves for CT and MR were 0.81 and 0.85, respectively (P = .06); that for scintigraphy was 0.83. Addition of scintigraphy to both CT and MR increased the areas under the ROC curves to 0.90 and 0.88, respectively. Accuracy of CT and MR for staging disease confined to the chest or abdomen (stages 1, 2, and 3) was poor.
CONCLUSION: MR alone and CT and MR combined with bone scintigraphy enable the accurate detection of stage 4 disease. Both CT and MR perform poorly for local tumor staging.
© RSNA, 2002
Index terms: Computed tomography (CT), comparative studies, 60.1211, 80.1211 Magnetic resonance (MR), comparative studies, 60.1214, 80.1214 Neoplasms, staging Neuroblastoma, 60.3251 Radionuclides, comparative studies, 60.1216, 80.1216
This article has been cited by other articles:
![]() |
G. W. L. Boland, M. A. Blake, P. F. Hahn, and W. W. Mayo-Smith Incidental Adrenal Lesions: Principles, Techniques, and Algorithms for Imaging Characterization Radiology, December 1, 2008; 249(3): 756 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rozovsky, B. Z. Koplewitz, Y. Krausz, S. Revel-Vilk, M. Weintraub, R. Chisin, and M. Klein Added Value of SPECT/CT for Correlation of MIBG Scintigraphy and Diagnostic CT in Neuroblastoma and Pheochromocytoma Am. J. Roentgenol., April 1, 2008; 190(4): 1085 - 1090. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. E. Moron, M. C. Morriss, J. J. Jones, and J. V. Hunter Lumps and Bumps on the Head in Children: Use of CT and MR Imaging in Solving the Clinical Diagnostic Dilemma RadioGraphics, November 1, 2004; 24(6): 1655 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lindskog, C. Spenger, J. Jarvet, A. Graslund, and P. Kogner Predicting Resistance or Response to Chemotherapy by Proton Magnetic Resonance Spectroscopy in Neuroblastoma J Natl Cancer Inst, October 6, 2004; 96(19): 1457 - 1466. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. H. Kushner Neuroblastoma: A Disease Requiring a Multitude of Imaging Studies J. Nucl. Med., July 1, 2004; 45(7): 1172 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hahn, M. Charron, B. L. Shulkin, M. J. Siegel, and F. A. Hoffer Role of MR Imaging and Iodine 123 MIBG Scintigraphy in Staging of Pediatric Neuroblastoma [letter] * Drs Siegel and Hoffer respond: Radiology, June 1, 2003; 227(3): 908 - 909. [Full Text] [PDF] |
||||
![]() |
J. C. Leonidas and M. J. Siegel MR Imaging in the Assessment of Staging of Neuroblastoma * Dr Siegel responds: Radiology, January 1, 2003; 226(1): 285 - 286. [Full Text] [PDF] |
||||
![]() |
N.-K. V. Cheung, B. H. Kushner, and M. J. Siegel Should We Replace Bone Scintigraphy Plus CT with MR Imaging for Staging of Neuroblastoma? * Dr Siegel responds: Radiology, January 1, 2003; 226(1): 286 - 288. [Full Text] [PDF] |
||||
![]() |
A. Mazumdar, M. J. Siegel, V. Narra, and L. Luchtman-Jones Whole-Body Fast Inversion Recovery MR Imaging of Small Cell Neoplasms in Pediatric Patients: A Pilot Study Am. J. Roentgenol., November 1, 2002; 179(5): 1261 - 1266. [Abstract] [Full Text] [PDF] |
||||
![]() |
A M Connors and S P Blake Multiple-choice questionnaire: general Imaging, October 1, 2002; 14(5): 428 - 437. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |